TTP vs Kaleidoscope Innovation: full comparison for 2026
Quick verdict
TTP (4.4/5) edges ahead of Kaleidoscope Innovation (4.0/5) overall. TTP is the better choice for pharma device programs, inhalers and injectors. Kaleidoscope Innovation is the stronger option for enterprises already working with Infosys. The right choice depends on your project size, budget, and required tech stack.
TTP vs Kaleidoscope Innovation: head-to-head summary
| Criterion | TTP | Kaleidoscope Innovation |
|---|---|---|
| Founded | 1987 | 1989 |
| HQ | Melbourn, Cambridgeshire, UK | Cincinnati, OH, USA |
| Team size | Not published | 100–250 |
| Rating | 4.4 / 5 | 4.0 / 5 |
| Primary differentiator | Employee ownership plus long-running drug delivery and surgical device work for large pharma and medtech clients | US medical design studio with access to Infosys engineering and digital capacity |
| Pricing model | Time and materials, phased fixed project | Time and materials, fixed project |
| Min. engagement | Not disclosed | Not disclosed |
| Primary tech stack | Ultrasound, Microfluidics, Embedded C/C++ | SolidWorks, Usability engineering, ISO 13485 QMS |
| Industries served | Drug delivery, Surgical & robotics, Diagnostics & lab devices | Surgical & therapeutic devices, Diagnostics & lab devices, Consumer products |
TTP vs Kaleidoscope Innovation: overview
TTP
TTP (The Technology Partnership) has operated for around 40 years from its own science park in Melbourn, South Cambridgeshire. In December 2021 TTP Group moved to 100% employee ownership through an Employee Ownership Trust. Its Medical Devices team works on drug delivery, surgical systems and diagnostics, and the wider company does deep technology work in sectors such as life science instruments and industrial products. Headcount is not published in a form we could verify.
Kaleidoscope Innovation
Kaleidoscope Innovation was founded in Cincinnati, Ohio, in 1989. Infosys acquired it in September 2020, and the deal coverage described its services as focused mainly on medical devices. It is listed as ISO 13485 certified and FDA compliant, and runs product development labs that it has expanded for healthcare clients. Headcount estimates range from about 100 to 250.
Services and capabilities: TTP vs Kaleidoscope Innovation
| Capability | TTP | Kaleidoscope Innovation |
|---|---|---|
| Electronics & PCB design | ✓ | ✓ |
| Firmware & embedded software | ✓ | ✗ |
| SaMD & companion apps | ✗ | ✗ |
| Connected devices & IoT | ✗ | ✗ |
| Industrial design & human factors | ✗ | ✓ |
| Mechanical engineering | ✓ | ✓ |
| Device cybersecurity | ✗ | ✗ |
| Regulatory & QMS support | ✓ | ✓ |
| Manufacturing & scale-up | ✗ | ✗ |
Tech stack comparison: TTP vs Kaleidoscope Innovation
| Framework / platform | TTP | Kaleidoscope Innovation |
|---|---|---|
| Embedded C/C++ | ✓ | N/A |
| Embedded Linux | N/A | N/A |
| RTOS | N/A | N/A |
| BLE | N/A | N/A |
| Cloud (AWS/Azure) | N/A | N/A |
| IEC 62304 | N/A | N/A |
| ISO 14971 | N/A | N/A |
| ISO 13485 QMS | ✓ | ✓ |
| Qt | N/A | N/A |
Pricing comparison: TTP vs Kaleidoscope Innovation
| Criterion | TTP | Kaleidoscope Innovation |
|---|---|---|
| Minimum engagement | Not disclosed | Not disclosed |
| Engagement models | Consulting, Fixed project, Time & materials | Fixed project, Time & materials |
| Rate transparency | Not public | Not public |
| Price tier | Mid-market | Mid-market |
Target audience comparison: TTP vs Kaleidoscope Innovation
| Dimension | TTP | Kaleidoscope Innovation |
|---|---|---|
| Best company size | Startup to mid-market | Startup to mid-market |
| Best industries | Drug delivery, Surgical & robotics, Diagnostics & lab devices | Surgical & therapeutic devices, Diagnostics & lab devices, Consumer products |
| Best use cases | Designing an autoinjector or inhaler for a pharma combination product, Developing a surgical energy device | Industrial and mechanical design for a surgical instrument, Device testing in an accredited lab environment |
| Typical project type | Consulting | Fixed project |
TTP vs Kaleidoscope Innovation: pros and cons
| TTP | |
|---|---|
| + | Employee ownership since 2021 removes pressure from outside investors |
| + | Well regarded for drug delivery devices, an area where mechanics and human factors decide success |
| + | Own science park with lab and workshop space for physical prototyping |
| + | Specialist depth in ultrasound and fluidics |
| - | Does not publish headcount or rates, which makes early budgeting harder |
| - | UK-centric delivery; US clients work across time zones |
| - | Pricing sits with the premium Cambridge consultancies |
| Kaleidoscope Innovation | |
|---|---|
| + | ISO 13485 certified, with medical devices as its main focus |
| + | In-house test and prototyping labs |
| + | Infosys ownership adds software and digital scale |
| + | Over 30 years of product design work |
| - | Owned by Infosys since 2020, so pricing and contracts may follow a large IT services model |
| - | Electronics and embedded software depth is less visible than its design work |
| - | Team size data comes only from third-party estimates |
Who should choose TTP?
A typical fit: designing an autoinjector or inhaler for a pharma combination product.
Employee ownership plus long-running drug delivery and surgical device work for large pharma and medtech clients. Minimum engagement is not publicly disclosed. Works best with clients in Drug delivery, Surgical & robotics, Diagnostics & lab devices.
Who should choose Kaleidoscope Innovation?
A typical fit: industrial and mechanical design for a surgical instrument.
US medical design studio with access to Infosys engineering and digital capacity. Minimum engagement is not publicly disclosed. Works best with clients in Surgical & therapeutic devices, Diagnostics & lab devices, Consumer products.
Decision matrix: TTP vs Kaleidoscope Innovation
| Your situation | Recommended choice |
|---|---|
| You need full-ownership delivery on a defined project scope | TTP |
| You need a large dedicated team for an ongoing programme | Check each company's engagement model |
| Your budget is at the lower end | Compare: TTP (Not disclosed) vs Kaleidoscope Innovation (Not disclosed) |
| You need specialist depth in a specific vertical | TTP |
| You need staff augmentation or team extension | Neither; consider alternatives that offer staff aug |
| You need consulting before committing to a build | Both may offer discovery engagements |
Use case fit: TTP vs Kaleidoscope Innovation
| Use case | TTP fit | Kaleidoscope Innovation fit | Winner |
|---|---|---|---|
| Designing an autoinjector or inhaler for a pharma combination product | Strong | Limited | TTP |
| Developing a surgical energy device | Strong | Limited | TTP |
| Industrial and mechanical design for a surgical instrument | Limited | Strong | Kaleidoscope Innovation |
| Device testing in an accredited lab environment | Strong | Strong | Both equally |
Verdict: TTP vs Kaleidoscope Innovation
TTP (4.4/5) is the stronger overall choice for most Medical Device Development projects. Employee ownership plus long-running drug delivery and surgical device work for large pharma and medtech clients.
Kaleidoscope Innovation (4.0/5) is worth a look if you need device testing in an accredited lab environment. If your situation matches that, Kaleidoscope Innovation is a competitive option.
Related comparisons
TTP vs Kaleidoscope Innovation FAQ
Is TTP better than Kaleidoscope Innovation?
TTP (4.4/5) scores higher overall, but "better" depends on your use case. TTP's strongest advantage: employee ownership since 2021 removes pressure from outside investors. Kaleidoscope Innovation's strongest advantage: ISO 13485 certified, with medical devices as its main focus.
How do TTP and Kaleidoscope Innovation differ in pricing?
TTP uses time and materials, phased fixed project pricing. Kaleidoscope Innovation uses time and materials, fixed project pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.
Which is better for enterprise: TTP or Kaleidoscope Innovation?
Kaleidoscope Innovation is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.
What are the main differences between TTP and Kaleidoscope Innovation?
TTP's primary differentiator is: employee ownership plus long-running drug delivery and surgical device work for large pharma and medtech clients. Kaleidoscope Innovation's primary differentiator is: US medical design studio with access to Infosys engineering and digital capacity. They also differ in team size (Not published vs 100–250), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Drug delivery, Surgical & robotics vs Surgical & therapeutic devices, Diagnostics & lab devices).
Verify all details directly with each company before making a decision.